These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29777760)

  • 1. Peripheral Intravenous Volume Analysis (PIVA) for Quantitating Volume Overload in Patients Hospitalized With Acute Decompensated Heart Failure-A Pilot Study.
    Miles M; Alvis BD; Hocking K; Baudenbacher F; Guth C; Lindenfeld J; Brophy C; Eagle S
    J Card Fail; 2018 Aug; 24(8):525-532. PubMed ID: 29777760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral i.v. analysis (PIVA) of venous waveforms for volume assessment in patients undergoing haemodialysis.
    Hocking KM; Alvis BD; Baudenbacher F; Boyer R; Brophy CM; Beer I; Eagle S
    Br J Anaesth; 2017 Dec; 119(6):1135-1140. PubMed ID: 29028929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation.
    Miller WL; Mullan BP
    JACC Heart Fail; 2014 Jun; 2(3):298-305. PubMed ID: 24952698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
    Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Venous Waveform Analysis for Detecting Hemorrhage and Iatrogenic Volume Overload in a Porcine Model.
    Hocking KM; Sileshi B; Baudenbacher FJ; Boyer RB; Kohorst KL; Brophy CM; Eagle SS
    Shock; 2016 Oct; 46(4):447-52. PubMed ID: 27070329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting short-term mortality in advanced decompensated heart failure - role of the updated acute decompensated heart failure/N-terminal pro-B-type natriuretic Peptide risk score.
    Scrutinio D; Ammirati E; Passantino A; Guida P; D'Angelo L; Oliva F; Ciccone MM; Iacoviello M; Dentamaro I; Santoro D; Lagioia R; Sarzi Braga S; Guzzetti D; Frigerio M
    Circ J; 2015; 79(5):1076-83. PubMed ID: 25753469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Venous Pressure Measurements in Patients With Acute Decompensated Heart Failure (PVP-HF).
    Sperry BW; Campbell J; Yanavitski M; Kapadia S; Tang WHW; Hanna M
    Circ Heart Fail; 2017 Jul; 10(7):. PubMed ID: 28694355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Peripheral IntravenousVolume Analysis (PIVA) for Quantitating Volume Overload in Patients Hospitalized with Acute Decompensated Heart Failure-A Pilot Study" Journal of Cardiac Failure Vol. 24 No. 8, pp. 525-532.
    Miles M; Alvis BD; Hocking K; Baudenbacher F; Guth C; Lindenfeld J; Brophy C; Eagle S
    J Card Fail; 2019 Jul; 25(7):579-581. PubMed ID: 31345283
    [No Abstract]   [Full Text] [Related]  

  • 12. A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Pilot Study.
    Reeves GR; Whellan DJ; O'Connor CM; Duncan P; Eggebeen JD; Morgan TM; Hewston LA; Pastva A; Patel MJ; Kitzman DW
    JACC Heart Fail; 2017 May; 5(5):359-366. PubMed ID: 28285121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Acute Decompensated Heart Failure Among Hospital Inpatients: Incidence, Causes and Outcomes.
    Plant LD; Taylor DM; Worland T; Puri A; Ugoni A; Patel SK; Johnson DF; Burrell LM
    Heart Lung Circ; 2019 Mar; 28(3):406-413. PubMed ID: 29519692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bedside Ultrasound Assessment of Jugular Venous Compliance as a Potential Point-of-Care Method to Predict Acute Decompensated Heart Failure 30-Day Readmission.
    Simon MA; Schnatz RG; Romeo JD; Pacella JJ
    J Am Heart Assoc; 2018 Aug; 7(15):e008184. PubMed ID: 30371245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
    Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
    J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection Fraction.
    Reeves GR; Whellan DJ; Patel MJ; O'Connor CM; Duncan P; Eggebeen JD; Morgan TM; Hewston LA; Pastva AM; Kitzman DW
    Am J Cardiol; 2016 Jun; 117(12):1953-8. PubMed ID: 27156830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nurse-based strategy reduces heart failure morbidity in patients admitted for acute decompensated heart failure in Brazil: the HELEN-II clinical trial.
    de Souza EN; Rohde LE; Ruschel KB; Mussi CM; Beck-da-Silva L; Biolo A; Clausell N; Rabelo-Silva ER
    Eur J Heart Fail; 2014 Sep; 16(9):1002-8. PubMed ID: 25044072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous waveform analysis detects acute right ventricular failure in a rat respiratory arrest model.
    Lefevre RJ; Barajas MB; Balzer C; Baudenbacher FJ; Riess ML; Staudt G; Hernandez A; Eagle SS
    Pediatr Res; 2023 May; 93(6):1539-1545. PubMed ID: 36042330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.